Related Experiment Video
Updated: Dec 23, 2025

Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia
Published on: December 19, 2020
CT characteristics of patients infected with 2019 novel coronavirus: association with clinical type
1Department of Radiology, Tongde Hospital of Zhejiang Province, Hangzhou, China.
Insights
Chest CT scans reveal common abnormalities like ground-glass opacity and consolidation in COVID-19 patients. These imaging features can help assess disease severity and aid in early recognition of 2019 novel coronavirus (2019-nCov) infections.
Area of Science:
- Radiology
- Infectious Diseases
- Pulmonology
Background:
- The 2019 novel coronavirus (2019-nCov) outbreak has led to a global health crisis.
- Understanding the characteristic imaging findings of COVID-19 is crucial for prompt diagnosis and patient management.
Purpose of the Study:
- To summarize chest computed tomography (CT) features in patients with 2019-nCov infection.
- To enhance the recognition and understanding of COVID-19 disease through imaging analysis.
Main Methods:
- Retrospective review of clinical information and chest CT images from 93 patients diagnosed with 2019-nCov.
- Analysis of common and less common CT findings, including opacity, consolidation, and signs like crazy-paving and halo.
Main Results:
- 91 out of 93 patients showed subpleural abnormalities, predominantly ground-glass opacity (74.2%) and consolidation (60.2%) in multiple lobes.
- Vascular dilatation (89.2%) and bronchodilatation (47.3%) were frequent. Critical cases showed more consolidation, crazy-paving, and pleural abnormalities (p<0.05).
- Mild cases were more associated with ground-glass opacity and halo sign (p<0.05). Older age, fever, chest tightness, and lymphopenia correlated with severe infection.
Conclusions:
- Chest CT findings in COVID-19 are diverse and correlate with disease severity.
- Imaging features can provide valuable insights into the clinical status and progression of COVID-19.
Aim:
To summarise the features of chest computed tomography (CT) of a series of patients infected with 2019 novel coronavirus (2019-nCov) to speed up recognition and have a better understanding of COVID-19 disease.
Materials And Methods:
The clinical information and chest CT images of 93 patients infected with 2019-nCov from multiple centres were reviewed.
Results:
Of the 93 cases, abnormalities in 91 cases were located at the subpleural level, presenting with ground-glass opacity (GGO; n=69, 74.2%) and consolidation (n=56, 60.2%) in multiple lobes. Other CT features included vascular dilatation (n=83, 89.2%), interlobular septal thickening (n=29, 31.2%), bronchodilatation (n=44, 47.3%), the crazy-paving sign (n=34, 36.6%), the sieve-hole sign (n=12, 12.9%), pleural thickening (n=21, 22.6%), and pleural effusion (n=8, 8.6%). Multiple lobe involvement, including the presence of consolidation, the crazy-paving sign, interlobular septal thickening, pleural thickening and pleural effusion, was more common in critical patients with heavy/critical infection (p<0.05), whereas the presence of GGO, involvement of one or two lobes, and the halo sign were more common in patients with mild/common-type infections (p<0.05). Moreover, older age, higher body temperature, complaints of chest tightness and breathlessness, and lymphopenia was associated with heavy/critical infections.
Conclusion:
The CT and clinical appearances of COVID-19 are variable and reflect the severity of COVID-19 to some extent.
More Related Videos
Related Concept Videos
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Endocarditis II: Clinical Features of Infective Endocarditis
Myocarditis II: Clinical Features and Diagnostic Tests
Coronary Artery Disease III: Clinical Manifestations
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:

